Cramer's Lightning Round: Hold on to Badger Meter
Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...
Cramer's Lightning Round: Energy Transfer is a buy
Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...
Lightning Round: I can't green light Rivian right now, says Jim Cramer
'Mad Money' host Jim Cramer weighs in on stocks including: Martin Marietta, Serve Robotics, Badger Meter, Rivian, and Arista ...
Lightning Round: Wait, don't sell, e.l.f. Beauty, says Jim Cramer
For gardeners, squirrels can present challenges, as they are capable of ruining the hard work you do by digging in flower ...
Cramer's Lightning Round: ‘I don't want to be a part of' Nebius
Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...
Cramer's Lightning Round: Sell Wendy's
Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...
Lightning Round: Ring the register on Whirlpool, says Jim Cramer
Tymofiy Mylovanov, a former Member of President Zelensky’s administration, joins CNN Michael Smerconish to discuss the latest ...
CNBC on MSN9d
Cramer's Lightning Round: Sunoco is a buy
It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to ...
Lightning Round: Very, very skeptical of nuclear power trades, says Jim Cramer
'Mad Money' host Jim Cramer weighs in on stocks including: Celestica, KeyCorp, Interactive Brokers, Nebius, BWX Technologies, and Nuscale Power. Posted: February 28, 2025 | Last updated: February 28, ...
Lightning Round: When Amazon goes down it's a 'gift', says Jim Cramer
'Mad Money' host Jim Cramer weighs in on stocks including: Dutch Bros, Archer Aviation, Amazon, Alphabet, and Red Cat. Posted ...
Lightning Round: Own Arm Holdings for the long-term, says Jim Cramer
The Journal of the American Medical Association published a review of more than 100 clinical trials that found at least 2.5 ...